血清抗苗勒管激素、性激素水平对多囊卵巢综合征的诊断价值

doi:10.3969/j.issn.1671-7171.2023.11.018

Abstract
Figure/Table
References
Related Citation (5)

Download: PDF (1235 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To investigate the diagnostic value of serum anti-Mullerian hormone(AMH) and sex hormone levels in the diagnosis of polycystic ovary syndrome(PCOS). 【Methods 】A total of 36 patients with PCOS admitted to our hospital from April 2020 to September 2023 were selected as the observation group,and 39 healthy women who underwent AMH and sex hormone level testing during the same period were selected as the control group.The serum AMH levels and sex hormone levels [follicle stimulating hormone(FSH),luteinizing hormone(LH),estradiol(E₂),testosterone(T)] were compared between the two groups,and the diagnostic value of serum AMH and sex hormone levels for PCOS was analyzed using receiver operating characteristic(ROC) curve. 【Results 】The serum AMH,LH,and T levels in the observation group were significantly higher than those in the control group,and the difference was statistically significant(P<0.05). There was no significant difference in serum E₂ and FSH levels between the two groups(P>0.05). ROC curve analysis showed that the area under the curve of serum AMH in the diagnosis of PCOS was 0.761(95%CI:0.643-0.878,P<0.001),T was 0.660(95%CI:0.536-0.784,P=0.017),and LH was 0.611(95%CI:0.480-0.742,P=0.067). Serum AMH level had the highest diagnostic value for PCOS. 【Conclusion】The serum AMH,LH,and T levels in patients with PCOS were significantly increased,and both serum AMH and T levels had certain diagnostic value for PCOS,with serum AMH having the highest diagnostic value.

Key words： Anti-Mullerian Hormone/BL Gonadal Steroid Hormones/BL Polycystic Ovary Syndrome/DI

Received: 23 October 2023

PACS:

R711.75

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	HAN Xinmei
	YAN Xianghong

Cite this article:

HAN Xinmei,YAN Xianghong. Diagnostic Value of Serum Anti-Mullerian Hormone and Sex Hormone Levels in Polycystic Ovary Syndrome[J]. JOURNAL OF CLINICAL RESEARCH, 2023, 40(11): 1677-1679.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2023.11.018 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2023/V40/I11/1677

[1] SIDDIQUI S,MATEEN S,AHMAD R,et al. A brief insight into the etiology,genetics,and immunology of polycystic ovarian syndrome(PCOS)[J].J Assist Report Genet,2022,39(11):2439-2473.
[2] 李卉,杨冬梓.《2018年多囊卵巢综合征评估与管理国际循证指南》之第一章(诊断及风险评估)解读[J].实用妇产科杂志,2023,39(2):113-116.
[3] THACKRAY V G. Sex,Microbes,and Polycystic Ovary Syndrome[J].Trends Endocrinol Metab,2019,30(1):54-65.
[4] 岳艳,马亚琳,张毅,等. 不孕症女性血清免疫抗体、AMH、FSH水平表达及其临床意义[J].中国妇产科临床杂志,2020,21(5):537-538.
[5] ROTTERDAM ESHRE/ASRM-SPONSORED PCOS CONSENSUS WORKSHOP GROUP. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome[J].Hum Reprod,2004,81(1):41-47.
[6] SADEGHI H M,ADELI I,CALINA D,et al. Polycystic ovary syndrome:a comprehensive review of pathogenesis,management,and drug repurposing[J].Int J Mol Sci,2022,23(2):583.
[7] 柳丽佳,邵铜,方媛,等.1990—2019年中国多囊卵巢综合征发病趋势分析[J].中国预防医学杂志,2023,24(3):259-263.
[8] DAPAS M,DUNAIF A. Deconstructing a syndrome:genomic insights into PCOS causal mechanisms and classification[J].Endocr Rev,2022,43(6):927-965.
[9] 宋伟东,于夫尧,傅紫薇,等.MRI对于多囊卵巢综合征卵巢改变的研究价值[J].医学影像学杂志,2023,33(8):1468-1471.
[10] 李丽丽.血清AMH、性激素及维生素D联合检测在多囊卵巢综合征中的应用价值[J].检验医学与临床,2023,20(11):1550-1552.
[11] 顾小铃,陈艳男,王迪,等.30～44岁不孕女性IVF/ICSI中优胚数与AMH的关系分析[J].中国计划生育和妇产科,2023,15(9):59-64.
[12] 徐进,张莹,王悦,等.甲状腺自身抗体与抗苗勒管激素的相关性及对体外受精助孕结局的影响[J].中华实用诊断与治疗杂志,2023,37(9):907-910.
[13] 张玲,周佳,吕松杰,等.基于广义相加模型分析血清AMH对ART治疗中获卵数和累计活产结局的效应研究[J].生殖医学杂志,2023,32(8):1140-1149.
[14] 高雅,鲁娣,宋殿荣.抗苗勒管激素在多囊卵巢综合征发病及诊治中的作用[J].国际妇产科学杂志,2023,50(5):540-544.
[15] 冯晓玲,尹文卿,王颖,等.多囊卵巢综合征患者游离睾酮指数水平与临床指标的相关性分析[J].中国全科医学,2023,26(24):3005-3009.